Retrospective Analysis of Efficacy and Safety of Tocilizumab Treatment in Patients with Severe Systemic-Onset Juvenile Idiopathic Arthritis Followed for 12 Months

Table 1

Demographic and clinical characteristics of patients with sJIA included in the study.

Parameter	Value median (25; 75); (𝑛=75)
Girls/boys	35/40
Age, years	8.8 (6; 12)
Disease duration, years	3.2 (1.9; 5.2)
The number of joints with active arthritis	8 (4; 17)
The number of joints with limitation of motion	9 (3; 17)
CHAQ index of functional disability	1.25 (0.75; 2.0)
The number of systemic manifestations per one patient	3.2 (2.5; 4)
ESR, mm/h	52 (22; 62)
Platelets, ×10^9/L	650 (495; 800)
Hemoglobin, g/L	89 (80; 98)
CRP, mg/L	78 (40; 98)